Analytics

Equity Analytics

Equity Analytics/HLN.L

HLN.L

Haleon plc

Healthcare - GB

Haleon plc is a leading global consumer healthcare company that develops and markets a broad portfolio of over-the-counter products across six key categories: oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory h…

HQ: Weybridge, SU, United Kingdomwww.haleon.com

GBP344.80+1.06%vs prev. close

Performance

+0.15%

-3.91%

-4.67%

-9.76%

YTD

-8.96%

Valuation

P/E

19.2

EPS TTM

0.18

Dividend yield

2.14%

Size and risk

Market cap

$40.1B

Beta

0.29

Price history

HLN.L price

USD

VolumeLog scale

Loading ADR price history...

Next earnings

Report date

EPS estimate

Revenue estimate

Peer comparison

Haleon
HLN.L
Drug Manufacturers - Specialty & Generic
Mkt cap (USD bn)
40.1
P/E
19.2
Div yld
2.14%
1W
+0.1%
1M
-3.9%
3M
-4.7%
6M
+3.7%
1Y
-9.8%
YTD
-9.0%

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Haleon	HLN.L	Drug Manufacturers - Specialty & Generic	40.1	19.2	2.14%	+0.1%	-3.9%	-4.7%	+3.7%	-9.8%	-9.0%

Subscribe to Equity Analytics to compare HLN.L with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

Ask, then keep asking: it follows the conversation for 30 minutes, grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.